Evidence map›Paper›PMID 32711929›Full record

ArticleAnais brasileiros de dermatologia

Spitz nevus and infliximab: association or coincidence?

Catarina Soares Queirós, André Laureano-Oliveira, Dolores Lopéz-Presa, Paul Filipe

Open access · goldAbstract readCase Reports
In one paragraph

Article in Anais brasileiros de dermatologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Catarina Soares QueirósDermatology Department, Hospital Santa Maria, Centro Hospitalar e Universitário de Lisboa Norte, Lisbon, Portugal. Electronic address: catarina.squeiros@gmail.com.
André Laureano-OliveiraDermatology Department, Hospital Santa Maria, Centro Hospitalar e Universitário de Lisboa Norte, Lisbon, Portugal; Faculdade de Medicina de Lisboa, Lisbon, Portugal.
Dolores Lopéz-PresaPathology Department, Hospital de Santa Maria, Centro Hospitalar e Universitário de Lisboa Norte, Lisbon, Portugal.
Paul FilipeDermatology Department, Hospital Santa Maria, Centro Hospitalar e Universitário de Lisboa Norte, Lisbon, Portugal; Faculdade de Medicina de Lisboa, Lisbon, Portugal.
Centro Hospitalar Lisboa Norte · PTHospital de Santa Maria · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biological therapies, including anti-TNF agents, are important in the treatment of various chronic inflammatory diseases, including psoriasis, rheumatoid arthritis or inflammatory bowel disease. The increased use of these drugs translates into an increasing awareness of its adverse effects, which include malignancy. In this paper, we describe the case of a 28-year-old woman who developed a spitzoid melanocytic tumor after starting infliximab therapy for ulcerative colitis. The evidence for causality between anti-TNF and melanocytic proliferations is still sparse; nonetheless, treatment-associated immunosuppression seems to play a key role in this phenomenon. Therefore, a regular follow-up with a rigorous skin examination is essential in these patients. Noninvasive techniques such as dermoscopy or reflectance confocal microscopy are particularly useful diagnostic tools in these circumstances.

Indexed as

Nevus, Epithelioid and Spindle CellSkin NeoplasmsAdultDiagnosis, DifferentialFemaleHumansInfliximabTumor Necrosis Factor-alphaInfliximabTumor Necrosis Factor-alphaBiological agentsConfocal microscopyDermoscopyNevus, epithelioid and spindle cellSkin neoplasms

Identifiers

PMID32711929
PMCPMC7563016
OpenAlexW3041470124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.